Therapeutic Options and Perspectives in the Treatment of Androgenetic Alopecia

    Rafaela Lepkoski Chaves, Diego Martins Sanson, Eduarda Faria do Nascimento, Julia Cristina de Oliveira, J Esteves, Kellen Luanny Silva, Marina Nascimento Gomes, Rafaella Bosi Castro de Oliveira, Renata Viana Hoffmann Monteiro Guedes, Milena Ferreira Gandra
    Image of study
    TLDR The document concludes that more research is needed on treatments for hair loss in both men and women, especially on medication combinations and their benefits.
    The document discusses therapeutic options for androgenetic alopecia (AGA) in both sexes, based on a literature review. It was found that AGA is a multifactorial dermatopathy affecting both genders. Finasteride is more effective in men than in women, while Dutasteride is used when Finasteride is ineffective and may increase hair count more than Finasteride. Topical Minoxidil is the first choice for moderate alopecia, and surgical treatment includes scalp reduction surgery, hair transplantation, or a combination of both. Other less common or experimental therapies include prostaglandin analogs and antagonists, laser therapy, and stem cell therapy. The document concludes that most studies focus on men, who are more frequently affected, and highlights the need for further research on certain medications and the combination of treatments, as well as their comparative advantages.
    Discuss this study in the Community →